Received: 8 January 2021
Accepted: 11 April 2022
First Online: 26 April 2022
: The design and protocol of this study was approved by the Prisma Health -Upstate Institutional Review Board (IRB) on July 16th, 2020. The referenced research study received approval under exempt category number 4 in accordance with 45CFR46.104, which does not mandate patient signatures as risk is considered minimal. The IRB protocol number for reference is Pro00096627.
: No individual participants personal data is being published in this manuscript.
: The authors of this manuscript have no conflicts of interest to disclose for this project. As previously stated, the authors have no financial or personal stake in this project.